Caputulan, Jhon Mark A.
HRN: 23-42-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/03/2023
08/09/2023
IV
225 Mg
Q6H
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes